A 16-member sports medicine advisory committee will review the Florida High School Athletic Association’s (FHSAA) policy regarding performance-enhancing drugs (PED).

The FHSAA chose to conduct this review after a report linked several high school students to Biogenesis, the organization that was connected with the suspensions of 14 Major League Baseball players.

“We have to use that as a reminder that it’s not just professional athletes, collegiate athletes,” said FHSAA Executive Director Roger Dearing in a USA Today interview. “But also our high school students are in danger.”

Under the current policy, student-athletes can be suspended from competing if it is discovered they have used PEDs. Dearing believes that the current policy must be made stronger in order to strongly encourage student-athletes to avoid using PEDs to compete.

Individual drug testing will be the decision of the school district as the FHSAA does not randomly test student-athletes. In 2007, after the urging of a state lawmaker, a random drug test pilot program began. The FHSAA did more than 500 tests and only one result was positive.

A statewide testing program would be costly. Dearing estimates that if they were to test all 283,000 student-athletes at $150 per student it could cost $42 million a year.

The FHSAA is also looking at putting policies in place to deal with parents, coaches or doctors who provide a student-athlete with performance-enhancing drugs.